You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 13, 2025

Details for Patent: RE37035


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: RE37035
Title: Phenylacetic acid benzylamides
Abstract:Phenylacetic acid benzylamides having the following general structure ##STR1## wherein the substituents are defined herein, are disclosed, which compounds are hypoglcemic agents.
Inventor(s): Grell; Wolfgang (Biberach, DE), Hurnaus; Rudolf (Biberach, DE), Griss; Gerhart (late of Biberach, DE), Sauter; Robert (Laupheim, DE), Reiffen; Manfred (Biberach, DE), Rupprecht; Eckhard (Guntramsdorf, AT)
Assignee: Boehringer Ingelheim KG (Ingelheim, DE)
Application Number:08/946,602
Patent Claim Types:
see list of patent claims
Compound; Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent RE37035

Introduction

Patent RE37035, like any other patent, is a complex document that outlines the exclusive rights granted to the inventor for their innovation. To delve into the specifics of this patent, it is crucial to analyze its scope, claims, and the broader patent landscape.

Patent Overview

Patent RE37035 is a reissue patent, which means it is a re-examination and potential modification of an original patent. Reissue patents are often sought to broaden or narrow the claims of the original patent, correct errors, or make other significant changes.

Scope of the Patent

The scope of a patent is defined by its claims, which are the legal descriptions of the invention for which protection is sought. Here are some key aspects to consider:

Claim Structure

Patent claims are typically divided into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[3].

Claim Language

The language used in the claims is critical. It must be precise and clear to avoid ambiguity and ensure that the scope of the patent is well-defined. The length and count of independent claims can also indicate the breadth of the patent scope. Generally, narrower claims are associated with a higher probability of grant and a shorter examination process[3].

Claims Analysis

To understand the claims of Patent RE37035, one must examine each claim individually.

Independent Claims

Independent claims in Patent RE37035 would outline the core aspects of the invention. These claims should be broad enough to cover the essential features of the invention but not so broad that they encompass prior art or abstract ideas.

Dependent Claims

Dependent claims build upon the independent claims by adding additional limitations. These claims help to narrow the scope and provide more specific examples of the invention.

Example from Similar Patents

For instance, in the context of the 2024 USPTO guidance update, claims that merely involve abstract ideas or routine data processing steps without a practical application are not patent-eligible. However, claims that integrate these abstract ideas into a practical application, such as using separated audio components in a real-time speech recognition system, can be patent-eligible[1].

Patent Landscape

The patent landscape includes all relevant patents and intellectual property related to the field of the invention.

Prior Art

Understanding prior art is essential to determine the novelty and non-obviousness of the invention claimed in Patent RE37035. Prior art includes all publicly available information that existed before the filing date of the patent application.

Competing Patents

Analyzing competing patents in the same field can help identify potential overlaps and distinctions. This is crucial for determining the uniqueness and value of Patent RE37035.

Litigation and Enforcement

Patent litigation and enforcement are critical aspects of maintaining the exclusivity granted by a patent.

Infringement Cases

Cases like Provisur Technologies, Inc. v. Weber, Inc. highlight the importance of precise claim language and the need for clear evidence of infringement. In this case, the court's decision hinged on whether the defendant's product could be configured to infringe the claimed advance-to-fill embodiment[2].

Quality and Compliance

Ensuring the quality and compliance of patent claims is a priority for the USPTO.

USPTO Guidelines

The USPTO has developed correctness measures and compliance targets to improve patent quality. These measures include statutory compliance rates for various sections of the patent code, such as 35 U.S.C. 101, 112, 102, and 103[4].

Practical Applications

Demonstrating practical applications of the claimed method or system is vital for patent eligibility.

Real-World Benefits

Claims that specify real-world applications, such as improving the accuracy of voice commands in hands-free environments, are more likely to be considered patent-eligible. This is because they provide tangible benefits and solve specific problems in the relevant field[1].

Key Takeaways

  • Clear Claim Language: The claims must be precise and clear to avoid ambiguity.
  • Practical Applications: Claims must integrate abstract ideas into practical applications to be patent-eligible.
  • Prior Art: Understanding prior art is crucial for determining novelty and non-obviousness.
  • Competing Patents: Analyzing competing patents helps identify uniqueness and value.
  • Litigation: Precise claim language and clear evidence are essential for infringement cases.
  • Quality and Compliance: Adhering to USPTO guidelines ensures the quality and validity of the patent.

FAQs

  1. What is the significance of independent and dependent claims in a patent? Independent claims define the core aspects of the invention, while dependent claims further limit and specify these claims.

  2. How does the 2024 USPTO guidance update impact AI-assisted inventions? The update clarifies that AI-assisted inventions are evaluated on equal footing with other technologies, provided there is significant human contribution and the claimed invention itself is patent-eligible[1].

  3. What role does prior art play in patent analysis? Prior art helps determine the novelty and non-obviousness of the invention by comparing it to existing publicly available information.

  4. Why is precise claim language important in patent litigation? Precise claim language helps avoid ambiguity and ensures that the scope of the patent is well-defined, which is critical in infringement cases.

  5. How does the USPTO ensure patent quality? The USPTO uses correctness measures and compliance targets, such as statutory compliance rates for various sections of the patent code, to ensure patent quality[4].

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. Provisur - United States Court of Appeals for the Federal Circuit
  3. Patent Claims and Patent Scope - SSRN
  4. Intellectual Property: Patent Office Should Define Quality, Reassess Incentives - GAO

More… ↓

⤷  Try for Free


Drugs Protected by US Patent RE37035

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

Foreign Priority and PCT Information for Patent: RE37035

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany3347565Dec 30, 1983
Germany3522604Jun 25, 1985
Germany3523466Jul 01, 1985

International Family Members for US Patent RE37035

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 3721084 ⤷  Try for Free
Australia 577815 ⤷  Try for Free
Austria 44027 ⤷  Try for Free
Austria 52255 ⤷  Try for Free
Austria 53028 ⤷  Try for Free
European Patent Office 0147850 ⤷  Try for Free SPC/GB98/042 United Kingdom ⤷  Try for Free
European Patent Office 0147850 ⤷  Try for Free 99C0002 Belgium ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 7 of 7 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.